1. Home
  2. HALO vs PFSI Comparison

HALO vs PFSI Comparison

Compare HALO & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • PFSI
  • Stock Information
  • Founded
  • HALO 1998
  • PFSI 2008
  • Country
  • HALO United States
  • PFSI United States
  • Employees
  • HALO N/A
  • PFSI N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • PFSI Finance: Consumer Services
  • Sector
  • HALO Health Care
  • PFSI Finance
  • Exchange
  • HALO Nasdaq
  • PFSI Nasdaq
  • Market Cap
  • HALO 6.4B
  • PFSI 5.7B
  • IPO Year
  • HALO N/A
  • PFSI 2013
  • Fundamental
  • Price
  • HALO $49.00
  • PFSI $105.61
  • Analyst Decision
  • HALO Buy
  • PFSI Buy
  • Analyst Count
  • HALO 9
  • PFSI 8
  • Target Price
  • HALO $61.11
  • PFSI $110.75
  • AVG Volume (30 Days)
  • HALO 2.3M
  • PFSI 268.0K
  • Earning Date
  • HALO 10-31-2024
  • PFSI 10-22-2024
  • Dividend Yield
  • HALO N/A
  • PFSI 1.14%
  • EPS Growth
  • HALO 61.71
  • PFSI N/A
  • EPS
  • HALO 3.02
  • PFSI 3.20
  • Revenue
  • HALO $947,355,000.00
  • PFSI $2,777,781,000.00
  • Revenue This Year
  • HALO $23.36
  • PFSI N/A
  • Revenue Next Year
  • HALO $15.15
  • PFSI $39.41
  • P/E Ratio
  • HALO $16.21
  • PFSI $33.06
  • Revenue Growth
  • HALO 21.35
  • PFSI 83.37
  • 52 Week Low
  • HALO $33.15
  • PFSI $76.58
  • 52 Week High
  • HALO $65.53
  • PFSI $119.13
  • Technical
  • Relative Strength Index (RSI)
  • HALO 43.09
  • PFSI 54.48
  • Support Level
  • HALO $42.01
  • PFSI $100.02
  • Resistance Level
  • HALO $46.20
  • PFSI $105.11
  • Average True Range (ATR)
  • HALO 2.76
  • PFSI 2.90
  • MACD
  • HALO -1.08
  • PFSI 0.45
  • Stochastic Oscillator
  • HALO 34.74
  • PFSI 84.40

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About PFSI PennyMac Financial Services Inc.

PennyMac Financial Services Inc is a United States-based financial services company primarily engaged in mortgage lending. The company operates through three segments: production, servicing, and investment management. The company's production and servicing segment together form the mortgage banking business that includes mortgage loan origination, acquisition, and sale activities; while the investment management segment includes investment manager's activities, such as performing diligence, and managing acquired assets. The company generates the majority of revenue from its mortgage banking business.

Share on Social Networks: